Outcomes of Embryos Created From Abnormally Fertilized Oocytes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorInception Fertility Research Institute, LLC
About this trial
The purpose of this study is to retrospectively analyze data from multiple clinics in a fertility network on embryos that were created from abnormally fertilized oocytes (AFO) including the rate of transfers and any clinical outcomes in order to inform providers in their decision making regarding AFOs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Underwent in vitro fertilization which resulted in a blastocyst derived from an abnormally fertilized embryo
Disqualifiers
None
Trial population
Females of varying age, race, and ethnicity who underwent in vitro fertilization which resulted in a blastocyst derived from an abnormally fertilized embryo
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Clinical Outcomes
For blastocysts derived from AFOs that were transferred, clinical outcomes include implantation rate, ongoing pregnancy rate, live birth rate, and spontaneous abortion rate.
Time frame
From embryo transfer to deliveryLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Inception Fertility Research Institute, LLC
Lead sponsor
Igenomix
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: